Ad A. van Bodegraven

Zuyderland Medisch Centrum — Netherlands

Biochemistry, Genetics and Molecular Biology · Life Sciences

46h-index8.1kcitations151works3.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Inflammatory Bowel Disease(83), Microscopic Colitis(49), Acute Lymphoblastic Leukemia research(22), Immunodeficiency and Autoimmune Disorders(13), Pregnancy and Medication Impact(12)

Publications150 total

P0027 The carbon footprint of remote monitoring of IBD patients – a green opportunity for sustainable outpatient care
Journal of Crohn s and Colitis·2025· 3 cited
Exposure to Thioguanine During 117 Pregnancies in Women With Inflammatory Bowel Disease
Journal of Crohn s and Colitis·2022· 16 citedOpen Access
Gene expression responses reflecting 5-FU-induced toxicity: Comparison between patient colon tissue and 3D human colon organoids
Toxicology Letters·2022· 5 citedOpen Access
P687 Prevalence of iron deficiency and anaemia in the outpatient Inflammatory Bowel Disease population: a Dutch national cross-sectional study
Journal of Crohn s and Colitis·2022· 1 citedOpen Access
DOP75 Effectiveness and Safety of tofacitinib versus vedolizumab in Patients with Ulcerative Colitis; A Nationwide, ICC Registry study
Journal of Crohn s and Colitis·2022Open Access
Severe COVID-19 in inflammatory bowel disease patients in a population-based setting
PLoS ONE·2021· 15 citedOpen Access
Feasibility and Efficiency of the BEFORE (Better Exercise and Food, Better Recovery) Prehabilitation Program
Nutrients·2021· 29 citedOpen Access
DOP54 Real-world effectiveness of thiopurine monotherapy in Crohn’s Disease: Is there still a place for thiopurines in the biological era?
Journal of Crohn s and Colitis·2021Open Access
P637 Incidence rate and clinical outcome of severe COVID-19 in Inflammatory Bowel Disease patients in a population-based setting
Journal of Crohn s and Colitis·2021Open Access
Poor nutritional status, risk of sarcopenia and nutrition related complaints are prevalent in COVID-19 patients during and after hospital admission
Clinical Nutrition ESPEN·2021· 106 citedOpen Access
Outcome of Reverse Switching From CT-P13 to Originator Infliximab in Patients With Inflammatory Bowel Disease
Inflammatory Bowel Diseases·2021· 26 citedOpen Access
Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn's disease: retrospective long-term follow-up of the LIR!C trial
˜The œLancet. Gastroenterology & hepatology·2020· 174 cited
Cost-effectiveness of Telemedicine-directed Specialized vs Standard Care for Patients With Inflammatory Bowel Diseases in a Randomized Trial
Clinical Gastroenterology and Hepatology·2020· 95 citedOpen Access
P326 Reasons for and effectiveness of switching back to originator infliximab after a prior switch to CT-P13 biosimilar
Journal of Crohn s and Colitis·2020· 3 cited
DOP58 Tofacitinib for ulcerative colitis: Results of the ICC Registry, a nationwide prospective observational cohort study
Journal of Crohn s and Colitis·2020Open Access
Perspective on skeletal health in inflammatory bowel disease
Osteoporosis International·2019· 39 citedOpen Access
Vulvar and vaginal neoplasia in women with inflammatory bowel disease
Digestive and Liver Disease·2019· 3 cited
Risk of impaired nutritional status and flare occurrence in IBD outpatients
Digestive and Liver Disease·2019· 23 citedOpen Access
Novel Perceived Stress and Life Events Precede Flares of Inflammatory Bowel Disease: A Prospective 12-Month Follow-Up Study
Journal of Crohn s and Colitis·2018· 46 citedOpen Access
Variability of core microbiota in newly diagnosed treatment-naïve paediatric inflammatory bowel disease patients
PLoS ONE·2018· 61 citedOpen Access
page 1 of 8Next →

Frequent Co-authors

Bas Oldenburg(19), C. Janneke van der Woude(18), Gerard Dijkstra(16), Dirk J. de Jong(15), Nofel Mahmmod(13), Cyriel Y. Ponsioen(13), Andrea E. van der Meulen‐de Jong(12), Peter D. Siersema(12), Mariëlle Romberg‐Camps(11), Jeroen M. Jansen(10), Pieter Stokkers(10), Nanne K.H. de Boer(10), Herma H. Fidder(8), Marieke Pierik(8), Chris J. Mulder(8), Clemens Bolwerk(7), Mirthe E. van der Valk(6), Marie‐Josée J. Mangen(6), Cees H. Clemens(6), Paul C. van de Meeberg(6)